康辰药业：累计回购约40万股

Group 1 - The core point of the article is that Kangchen Pharmaceutical has announced a share buyback program, having repurchased approximately 400,000 shares, which represents 0.25% of the company's total share capital, with a total expenditure of about 20.16 million yuan [1] - The highest purchase price for the repurchased shares was 51.4 yuan per share, while the lowest was 49.69 yuan per share [1] - As of the report, Kangchen Pharmaceutical's market capitalization stands at 7.3 billion yuan [1] Group 2 - For the fiscal year 2024, Kangchen Pharmaceutical's revenue composition indicates that 99.88% of its revenue comes from the pharmaceutical manufacturing sector, with only 0.12% from other business activities [1]